Health Care / Hospitals
Releases published in the last 30 days. 
Page 1 of 3
- Tesco Mother’s Day cards go on sale in support of Race for Life
- 3/20/2019 11:12:04 AM
- Tesco has launched a range of Mother’s Day cards to raise money for Cancer Research UK. On the back of the card, eight women, who all work for the supermarket, share how their lives, or the lives of those close to them, have been affected by cancer and inspired them to take part in Race for Life.
- The Elizabeth Hospice Expands Its Summer Camp Program for Grieving Children and Teens
- 3/20/2019 6:00:00 AM
- San Diego youth who are coping with the death of a special person in their life can find support and comfort at Camp Spero, an overnight weekend grief camp hosted by The Elizabeth Hospice.
- Smithsonian Examines Health and Medicine Through Philanthropy Lens
- 3/19/2019 5:35:31 PM
- Philanthropy to support health and medicine is the focus of the updated exhibit “Giving in America” at the Smithsonian’s National Museum of American History.
- CDC Guidance on Lyme Rash Challenged
- 3/19/2019 9:00:00 AM
- Advocates for Lyme disease patients have filed an “information quality request for correction” complaint that challenges the Centers for Disease Control and Prevention’s (CDC’s) position on how frequently the bull’s-eye erythema migrans (EM) rash occurs in patients with Lyme disease.
- European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease
- 3/18/2019 2:50:06 PM
- • MabThera is the first biologic treatment approved for moderate to severe cases of the rare autoimmune disease pemphigus vulgaris (PV), and the first major advancement in the treatment of the disease in more than 60 years • PV is a rare and potentially life-threatening blistering condition which can cause severe pain and disfigurement • MabThera is now approved in …
- Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease
- 3/18/2019 2:18:46 PM
- The European Commission (EC) has approved a new indication for Praluent® (alirocumab), to reduce cardiovascular (CV) risk in adults with established atherosclerotic CV disease (ASCVD) by lowering low-density lipoprotein cholesterol (LDL-C) levels as an adjunct to correction of other risk factors.
- Alcon Announces Acquisition of PowerVision, Inc.
- 3/18/2019 2:11:37 PM
- • Acquisition demonstrates Alcon’s commitment to driving growth and innovation in advanced technology intraocular lenses (AT-IOLS) to meet the needs of cataract surgery patients who desire spectacle independence • US-based PowerVision, Inc.
- Philips recognized for design excellence at the iF Design Awards 2019
- 3/18/2019 1:27:32 PM
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has received 22 prestigious awards at the iF Design Awards 2019, including an iF Design Gold Award in the category ‘service and user experience design’ for its consulting project to plan the transformation of the endoscopy department at Good Samaritan Hospital, …
- New Practice Corrects Pump Function in Heart Failure
- 3/18/2019 10:17:08 AM
- Late-breaking results from the ElectroCRT trial presented today at EHRA 20191 a European Society of Cardiology (ESC) congress, pave the way for a new standard of care to improve the heart’s pump function in selected patients with heart failure.
- US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
- 3/18/2019 6:19:05 AM
- The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for saracatinib, a potential new medicine for the treatment of idiopathic pulmonary fibrosis (IPF), a type of lung disease that results in scarring (fibrosis) of the lungs.
- Researchers Develop Method to Dramatically Reduce Error Rate in Next-Generation Sequencing
- 3/15/2019 2:17:31 PM
- St. Jude Children’s Research Hospital investigators have developed software to shrink the error rate in next-generation sequencing data by as much as 100-fold, which would likely speed early detection of relapse and other threats.
- Sanofi Successfully Prices EUR 2 Billion of Bond Issues
- 3/15/2019 12:43:39 PM
- Sanofi announces that it has successfully priced its offering of EUR 2 billion of notes (the “Notes”) across 3 tranches: •€850 million fixed rate notes, due March 2022, bearing interest at an annual rate of 0.0% •€650 million fixed rate notes, due March 2029, bearing interest at an annual rate of 0.875% •€500 million fixed rate notes, due March 2034, bearing interest at an …
- 25th Annual Healthcare Ethics Conference Highlights Health Care Ethics in an Era of Change
- 3/15/2019 11:42:42 AM
- The Healthcare Ethics Consortium and the Emory Center for Ethics will host the 25th annual Healthcare Ethics conference on March 21 and 22 at the Emory Conference Center.
- Strong Opposition to New Restrictions in Medicaid
- 3/15/2019 10:24:02 AM
- As federal judge James Boasberg of the U.S. District Court for the District of Columbia prepares to hear oral arguments on the legality of Medicaid work requirements in Arkansas and Kentucky on Thursday, March 14, a coalition of Montana health providers, patient advocates and community leaders are urging legislators to continue Medicaid expansion without imposing unreasonable …
- Mammoth Biosciences Secures Exclusive License to Commercialize Novel CRISPR Protein
- 3/14/2019 3:33:00 PM
- Mammoth Biosciences, the company behind the world’s first CRISPR-based disease detection platform, announces the exclusive licensing of a new CRISPR protein, Cas14, from UC Berkeley, for use in all fields.
- New study finds significant differences in how various adaptive servo ventilation (ASV) devices treat complex sleep apnea
- 3/14/2019 11:21:11 AM
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced results from a recent study, Comparison of Physiological Performance of Four Adaptive Servo Ventilation Devices in Patients with Complex Sleep Apnea in the American Journal of Respiratory and Critical Care Medicine, showing adaptive servo ventilation (ASV) is an effective treatment …
- NWLC Celebrates Introduction of the EACH Woman Act
- 3/14/2019 7:18:24 AM
- The EACH Woman Act, or the Equal Access to Abortion Coverage in Health Insurance Act, was introduced in Congress, in both the House of Representatives and the Senate.
- EZShield + IdentityForce to Present Webinar, “Three Ways employers Can Add Value Through Supplemental Benefits”
- 3/12/2019 8:30:00 AM
- EZShield + IdentityForce, the leader in digital identity protection and resolution, today announced the presentation of a free, exclusive 15-minute webinar.
- Community Invited to Honor the Memory of Their Loved Ones in A Beautiful Way
- 3/12/2019 7:00:00 AM
- Everyone in the community is invited to attend Wings of Hope, hosted by The Elizabeth Hospice, on Sunday, April 28, 2019 from 1 to 3 pm. The event will take place at the California Center for the Arts, located at 340 N.
- Elsevier and the International Solar Energy Society (ISES) launch the second Renewable Transformation Challenge
- 3/11/2019 3:55:19 PM
- Elsevier, the information analytics business specializing in science and health, and the International Solar Energy Society (ISES), are pleased to announce the return of the Renewable Transformation Challenge, following the success of the first Challenge in 2017.
